(Z)-5-(4-((1-(4-bromobenzyl)-1H-1,2,3-triazol-4-yl)methoxy)benzylidene)thiazolidine-2,4-dione

ID: ALA4475190

PubChem CID: 155537482

Max Phase: Preclinical

Molecular Formula: C20H15BrN4O3S

Molecular Weight: 471.34

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1NC(=O)/C(=C/c2ccc(OCc3cn(Cc4ccc(Br)cc4)nn3)cc2)S1

Standard InChI:  InChI=1S/C20H15BrN4O3S/c21-15-5-1-14(2-6-15)10-25-11-16(23-24-25)12-28-17-7-3-13(4-8-17)9-18-19(26)22-20(27)29-18/h1-9,11H,10,12H2,(H,22,26,27)/b18-9-

Standard InChI Key:  UOCHXCVPYZVORD-NVMNQCDNSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   23.0051  -11.2347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0010  -12.0519    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   23.7769  -12.3084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2607  -11.6496    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.7836  -10.9862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1766  -11.2425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1755  -12.0621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8835  -12.4710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5932  -12.0616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5903  -11.2389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8817  -10.8337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2965  -10.8277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0255  -13.0868    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.0400  -10.2102    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.4674  -12.4701    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.7600  -12.0609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0442  -13.2855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0559  -12.4685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2825  -12.2049    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.7928  -12.8591    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2632  -13.5275    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.8545  -14.2352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0373  -14.2352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6304  -13.5267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8139  -13.5263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4045  -14.2345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8174  -14.9446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6325  -14.9415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5873  -14.2355    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
 10 12  1  0
 12  1  2  0
  3 13  2  0
  5 14  2  0
  7 15  1  0
 15 16  1  0
 16 18  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 17  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 26 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4475190

    ---

Associated Targets(Human)

PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PTGS1 Cyclooxygenase-1 (5266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pparg Peroxisome proliferator-activated receptor gamma (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 471.34Molecular Weight (Monoisotopic): 470.0048AlogP: 3.99#Rotatable Bonds: 6
Polar Surface Area: 86.11Molecular Species: ACIDHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 6.20CX Basic pKa: CX LogP: 4.04CX LogD: 2.89
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.55Np Likeness Score: -1.80

References

1. Elzahhar PA, Alaaeddine R, Ibrahim TM, Nassra R, Ismail A, Chua BSK, Frkic RL, Bruning JB, Wallner N, Knape T, von Knethen A, Labib H, El-Yazbi AF, Belal ASF..  (2019)  Shooting three inflammatory targets with a single bullet: Novel multi-targeting anti-inflammatory glitazones.,  167  [PMID:30818268] [10.1016/j.ejmech.2019.02.034]

Source